Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team.
J Acquir Immune Defic Syndr
; 21(4): 281-92, 1999 Aug 01.
Article
en En
| MEDLINE
| ID: mdl-10428106
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Zidovudina
/
Infecciones por VIH
/
VIH-1
/
Didanosina
/
Inhibidores de la Transcriptasa Inversa
/
Fármacos Anti-VIH
/
Delavirdina
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Año:
1999
Tipo del documento:
Article